publish date 2021-11-18 20:09:12
AstraZeneca Pharmaceutical Industries reported that a mixture of antibodies it developed to treat corona disease was effective in providing long-term protection by more than 80% in both preventing symptoms associated with the disease and stopping its exacerbation after six months.
Today, Thursday, the company added that the drug reduced the risk of developing corona symptoms by 83% in one of the experiments, after six months of follow-up.
She pointed out that during the other experiment, which relied on data over a period of half a year from participants who attended outpatient clinics while they had mild to moderate symptoms, it was found that the mixture reduces the risk of serious symptoms or death related to the disease by 88%.
#AstraZeneca #develops #treatment #longterm #protection #corona
Jordan Miscellaneous news
Source : اخبار الاردن